Found: 14
Select item for more details and to access through your institution.
Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231221340
- By:
- Publication type:
- Article
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 523, doi. 10.1002/ajh.27207
- By:
- Publication type:
- Article
Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 11, p. 3195, doi. 10.1007/s00277-023-05427-8
- By:
- Publication type:
- Article
Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 1, p. 77, doi. 10.20892/j.issn.2095-3941.2022.0612
- By:
- Publication type:
- Article
OAB-011: Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single cell level.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S7, doi. 10.1016/S2152-2650(21)02085-1
- By:
- Publication type:
- Article
Clinical Characteristics, Survival Outcomes and prognosis in 82 Immunoglobulin D Multiple Myeloma Patients: A Retrospective Single-Center Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e304, doi. 10.1016/j.clml.2019.09.499
- By:
- Publication type:
- Article
The impact of response kinetics following initial therapy for multiple myeloma in the era of novel agents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e222, doi. 10.1016/j.clml.2019.09.370
- By:
- Publication type:
- Article
The prognostic impact of dynamic changing of cytogenetic abnormalities under the treatment options in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e221, doi. 10.1016/j.clml.2019.09.368
- By:
- Publication type:
- Article
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates the therapy-induced clonal selection in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e187, doi. 10.1016/j.clml.2019.09.313
- By:
- Publication type:
- Article
Multiple high-risk cytogenetic aberrations confer a progressively negative impact on survivals of newly diagnosed myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e83, doi. 10.1016/j.clml.2019.09.132
- By:
- Publication type:
- Article
IgH translocations with undefined partners are associated with superior outcome in multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e82, doi. 10.1016/j.clml.2019.09.131
- By:
- Publication type:
- Article
The prognostic value of 1q21 gain does not rely on the copy numbers, clone size and concurrence with t(4;14).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e62, doi. 10.1016/j.clml.2019.09.097
- By:
- Publication type:
- Article
Early relapse within 18 months is a powerful dynamic predictor for prognosis and could revise static risk distribution in multiple myeloma.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 3, p. 421, doi. 10.1002/cncr.35056
- By:
- Publication type:
- Article
A Sole p.G391E Mutation in PML::RARA Identified in Relapsed Acute Promyelocytic Leukemia.
- Published in:
- Turkish Journal of Hematology, 2024, v. 41, n. 3, p. 200, doi. 10.4274/tjh.galenos.2024.2024.0157
- By:
- Publication type:
- Article